Soybean Oil Is More Obesogenic and Diabetogenic than Coconut Oil and Fructose in Mouse: Potential Role for the Liver
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
The obesity epidemic in the U.S. has led to extensive research into potential contributing dietary factors, especially fat and fructose. Recently, increased consumption of soybean oil, which is rich in polyunsaturated fatty acids (PUFAs), has been proposed to play a causal role in the epidemic. Here, we designed a series of four isocaloric diets (HFD, SO-HFD, F-HFD, F-SO-HFD) to investigate the effects of saturated versus unsaturated fat, as well as fructose, on obesity and diabetes. C57/BL6 male mice fed a diet moderately high in fat from coconut oil and soybean oil (SO-HFD, 40% kcal total fat) showed statistically significant increases in weight gain, adiposity, diabetes, glucose intolerance and insulin resistance compared to mice on a diet consisting primarily of coconut oil (HFD). They also had fatty livers with hepatocyte ballooning and very large lipid droplets as well as shorter colonic crypt length. While the high fructose diet (F-HFD) did not cause as much obesity or diabetes as SO-HFD, it did cause rectal prolapse and a very fatty liver, but no balloon injury. The coconut oil diet (with or without fructose) increased spleen weight while fructose in the presence of soybean oil increased kidney weight. Metabolomics analysis of the liver showed an increased accumulation of PUFAs and their metabolites as well as γ-tocopherol, but a decrease in cholesterol in SO-HFD. Liver transcriptomics analysis revealed a global dysregulation of cytochrome P450 (Cyp) genes in SO-HFD versus HFD livers, most notably in the Cyp3a and Cyp2c families. Other genes involved in obesity (e.g., Cidec, Cd36), diabetes (Igfbp1), inflammation (Cd63), mitochondrial function (Pdk4) and cancer (H19) were also upregulated by the soybean oil diet. Taken together, our results indicate that in mice a diet high in soybean oil is more detrimental to metabolic health than a diet high in fructose or coconut oil.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., Mullany, E. C., Biryukov, S., Abbafati, C., Abera, S. F., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60460-8 · Cited by 11,952
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Trumbo, P., Schlicker, S., Yates, A. A., & Poos, M. (2002) · Journal of the American Dietetic Association · doi:10.1016/s0002-8223(02)90346-9 · Cited by 5,993
p21 in cancer: Intricate networks and multiple activities
Abbas, T., & Dutta, A. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2657 · Cited by 2,712 · cited 1×
“While p21 is best known as a target of tumor suppressor p53 and an inhibitor of the cell cycle [137,138], it has also been reported to exhibit oncogenic activity [139].”
BackgroundAdipocyte differentiation from the inside out
Rosen, E. D., & MacDougald, O. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2066 · Cited by 2,607
Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation
Watanabe, M., Houten, S. M., Mataki, C., Christoffolete, M. A., Kim, B. W., Sato, H., Messaddeq, N., Harney, J. W., Ezaki, O., Kodama, T., et al. (2006) · Nature · doi:10.1038/nature04330 · Cited by 2,220 · cited 1×
“This could result in lower levels of bile acids, which are known to play anti-obesogenic roles [82,83].”
BackgroundOmega-3 fatty acids in health and disease and in growth and development.
Simopoulos, A. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.3.438 · Cited by 2,162 · cited 1×
“Also elevated at 35 weeks in SO-HFD were α-linolenic acid (LNA, 18:3ω3 or 6) and eicopentaenoic acid (EPA, 20:5ω3), which should have a beneficial effect [85,86].”
BackgroundFat and Beyond: The Diverse Biology of PPARγ
Tontonoz, P., & Spiegelman, B. M. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.061307.091829 · Cited by 2,085 · cited 4×
“Many of the Cyp genes, Cidec, Pdk4, Vnn1, Igfbp1, Acot2, Rgs3 and Tceal8 and other dysregulated genes in SO-HFD compared to HFD are HNF4α target genes [157–161].”
BackgroundInfluentialSugar-Sweetened Beverages, Obesity, Type 2 Diabetes Mellitus, and Cardiovascular Disease Risk
Malik, V. S., Popkin, B. M., Bray, G. A., Després, J.-P., & Hu, F. B. (2010) · Circulation · doi:10.1161/circulationaha.109.876185 · Cited by 1,641
Metabolic Effects of Fructose and the Worldwide Increase in Obesity
Tappy, L., & Lê, K.-A. (2010) · Physiological Reviews · doi:10.1152/physrev.00019.2009 · Cited by 1,256
2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk
Eckel, R. H., Jakicic, J. M., Ard, J. D., de Jesus, J. M., Houston Miller, N., Hubbard, V. S., Lee, I.-M., Lichtenstein, A. H., Loria, C. M., Millen, B. E., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.003 · Cited by 1,160
Chowdhury, R., Warnakula, S., Kunutsor, S., Crowe, F., Ward, H. A., Johnson, L., Franco, O. H., Butterworth, A. S., Forouhi, N. G., Thompson, S. G., et al. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1788 · Cited by 1,139
Hayhurst, G. P., Lee, Y.-H., Lambert, G., Ward, J. M., & Gonzalez, F. J. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.4.1393-1403.2001 · Cited by 1,107 · cited 1×
“PPARγ is associated with obesity [154] while decreased HNF4α is associated with fatty liver in mice [155] and diabetes in humans [156].”
BackgroundEpidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026
Blasbalg, T. L., Hibbeln, J. R., Ramsden, C. E., Majchrzak, S. F., & Rawlings, R. R. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.006643 · Cited by 881 · cited 5×
“and worldwide [16,168] warrants a detailed understanding of its effect on our health.”
BackgroundInfluentialγ-Tocopherol, the major form of vitamin E in the US diet, deserves more attention
Jiang, Q., Christen, S., Shigenaga, M. K., & Ames, B. N. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.6.714 · Cited by 776 · cited 1×
“While α-tocopherol is the most dominant form of Vitamin E in the body, and the best studied [97], there are reports that γ-tocopherol may have more potent anti-inflammatory and anticancer properties [98,99].”
BackgroundThe role of fructose in the pathogenesis of NAFLD and the metabolic syndrome
Lim, J. S., Mietus-Snyder, M., Valente, A., Schwarz, J.-M., & Lustig, R. H. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.41 · Cited by 771 · cited 1×
“Fructose is known to increase de novo lipogenesis (and production of saturated fats) and cause fatty liver [55]; consistent with this, our results show that the F-HFD and F-SO-HFD mice also had excess fat in their livers (Fig 5D).”
ResultNational Estimates of Dietary Fructose Intake Increased from 1977 to 2004 in the United States
Marriott, B. P., Cole, N., & Lee, E. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.098277 · Cited by 473 · cited 1×
“Fructose consumption has increased from ~37 g/day in 1977 [29] to ~49 g/day in 2004, with the highest intake among teenage males (75 g/day) [30].”
BackgroundThe pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility
Zhang, S., Hulver, M. W., McMillan, R. P., Cline, M. A., & Gilbert, E. R. (2014) · Nutrition & Metabolism · doi:10.1186/1743-7075-11-10 · Cited by 450 · cited 2×
“The most notable gene was Pdk4, which was elevated four-fold in SO-HFD compared to HFD and encodes a mitochondrial gene that plays an important role in the balance between glucose and fatty acid oxidation [76].”
BackgroundBocarsly, M. E., Powell, E. S., Avena, N. M., & Hoebel, B. G. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.02.012 · Cited by 314
Hnf4: A Central Regulator of Hepatocyte Differentiation and Function
Watt, A. J., Garrison, W. D., & Duncan, S. A. (2003) · Hepatology · doi:10.1053/jhep.2003.50273 · Cited by 307
High-fat diet-induced hyperglycemia and obesity in mice: differential effects of dietary oils
Ikemoto, S., Takahashi, M., Tsunoda, N., Maruyama, K., Itakura, H., & Ezaki, O. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90185-7 · Cited by 276
In Vitro Antimicrobial Properties of Coconut Oil on Candida Species in Ibadan, Nigeria
Ogbolu, D. O., Oni, A. A., Daini, O. A., & Oloko, A. P. (2007) · Journal of Medicinal Food · doi:10.1089/jmf.2006.1209 · Cited by 127 · cited 1×
“Furthermore, our results show that soybean oil is able to induce these negative metabolic effects even in the context of coconut oil, which is rich in medium-chain triglycerides (MCTs) which have been shown to be anti-obesogenic, anti-inflammatory and insulin sensitizing [15,104,105].”
Background
Cited by
Mediterranean Diet and Prevention of Chronic Diseases
Romagnolo, D. F., & Selmin, O. I. (2017) · Nutrition Today · doi:10.1097/nt.0000000000000228 · Cited by 187
Patrone, V., Minuti, A., Lizier, M., Miragoli, F., Lucchini, F., Trevisi, E., Rossi, F., & Callegari, M. L. (2018) · BMC Genomics · doi:10.1186/s12864-018-5202-z · Cited by 47
Barreto, L. P., de Oliveira Silva, R. Y., de Almeida, B. B., Ovídio, P. P., & Jordao, A. A. (2023) · Gene Expression · doi:10.14218/ge.2022.00006 · Cited by 4
Metadata
- Authors
- Deol, P., Evans, J. R., Dhahbi, J., Chellappa, K., Han, D. S., Spindler, S., & Sladek, F. M.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-07-22
- Volume
- 10
- Issue
- 7
- Pages
- e0132672
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1551052904
- Cited by
- 96
- References
- 23
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.